Botox safety from meta-analysis data
Safety profile of Botox (botulinumtoxin A preparation: onabotulinumtoxinA) used for facial cosmetic purposes (wrinkles between the eyebrows, crow's feet, etc.) based on a large-scale meta-analysis integrating patient data from 9,669 individuals[1]and other sources.
Primary evidence source for this article: Meta-analysis[1]integrated data from 36 clinical trials on botulinumtoxin A preparation (onabotulinumtoxinA) in cosmetic applications. The analysis involved a total of 9,669 patients (Botox group: 6,009 patients; Placebo group: 3,660 patients)[4]. The analysis focused primarily on treatments of the upper face, such as glabellar wrinkles (22 trials) and crow's feet (11 trials), with adverse events systematically evaluated. By referencing large-scale data rather than individual anecdotes, we can objectively understand the types and frequencies of side effects.
Main adverse events reported in clinical data
- Pain and swelling at the injection site: The incidence of injection-site-related adverse events (pain, swelling, erythema, etc.) was reported as 23.6% in the Botox group versus 18.9% in the placebo group. In most cases, symptoms naturally resolve within 1–2 days [4].
- Bruising (ecchymosis): The incidence of injection-site bleeding or petechial hemorrhage is less than 10%, with most cases showing improvement within 1–2 weeks [4].
- Headache: The incidence in the Botox group was reported as 11.2% (placebo group 8.9%), and most cases are mild and temporary [4].
- Eyebrow ptosis and eyelid ptosis(blepharoptosis): The incidence of eyelid ptosis was 1.8% in the Botox group (0.2% in placebo group), considered to be primarily related to injection technique [4].
Most of the above adverse events are mild and transient. However, risk is not zero. At standard doses and administration methods for facial cosmetic purposes (e.g., 20 units between the eyebrows), severe adverse events are extremely rare. Allergic reactions such as anaphylaxis are not impossible. Therefore, always disclose your medical history and current medications to your physician.
On the other hand, domestic product inserts and FDA Boxed Warnings describe serious risks if botulinumtoxin effects diffuse beyond the intended area. These include dysphagia (difficulty swallowing), respiratory difficulty, voice hoarseness, and generalized muscle weakness. Such risks have been primarily reported in treatment indications requiring high doses (such as cervical dystonia) or off-label use in pediatric cerebral palsy patients, and the possibility of occurrence at doses used for facial cosmetic purposes is considered extremely low. However, caution is necessary, particularly in cases of off-label use on the neck, overdose, or history of neuromuscular disorders (such as myasthenia gravis), as risks may increase. Should any of these symptoms or strong discomfort occur after treatment, immediately contact the clinic or medical facility where you received the treatment and seek medical attention.
Patient satisfaction evaluation
Along with safety, patient satisfaction is an important evaluation metric. For example, in a large-scale Phase 3 randomized controlled trial targeting glabellar wrinkles, the primary outcome measure of "subject satisfaction with treatment results" showed that satisfaction in the Botox group was statistically significantly higher compared to the placebo group [5].
The following factors are considered to contribute to this high satisfaction:
- Predictability and reproducibility: Since the pharmacological action is clearly defined, the onset of effect and duration of action are considered somewhat predictable.
- Short downtime: Since the procedure is completed with injections only, there tends to be minimal activity restrictions after treatment. However, there are individual differences, such as bruising and swelling that may persist for several days to approximately two weeks.
- Reversibility: Since the effects gradually diminish over 3–6 months and results are not permanent, this is thought to be a factor that lowers the psychological barrier for patients receiving cosmetic medical treatment for the first time.
- Efficacy based on objective assessment: For example, in a Phase 3 clinical trial targeting glabellar lines, at 30 days post-treatment, 74.0% of subjects achieved improvement of 2 grades or more on both physician assessment (FWS) and patient assessment (FLS) [5]. Proper technique leads to these objective effects, which in turn result in subjective satisfaction with a natural appearance.
Positioning of Botox compared to other aesthetic treatments
Among aesthetic medicine options, Botox has the following characteristics.
Each treatment has different purposes and mechanisms of action, so a simple risk comparison is not possible; however, understanding differences in risk profiles based on the mechanism of action is important.
- Surgery (Faceliftetc.) comparison: It is a non-invasive injectable treatment and does not inherently carry risks unique to surgical procedures involving incisions (general anesthesia, post-operative scarring, extensive nerve damage, etc.).
- Hyaluronic acid injectionComparison with: Since the main component is liquid and not a gel-like filler, the risk of vascular embolism caused by the injection physically occluding blood vessels is theoretically extremely low.
- Comparison with laser treatment: Since the mechanism of action does not involve applying thermal energy to the skin surface, the types of risks such as thermal burns and post-inflammatory hyperpigmentation after irradiation are fundamentally different.
Each procedure has its own distinct risks and benefits, and a wise choice suited to your own goals is required.
The physician's skill greatly influences safety
It is extremely important that a physician with appropriate skill injects the correct amount into the correct location.
Eyelid ptosis is noted to result from incorrect injection placement or excessive dosage.
Key points for receiving safe treatment
- Knowledge of anatomy: It is essential to choose a physician who can understand the position and depth of the facial muscles.
- Treatment experience: It is important to choose a physician with extensive experience in Botox treatments.
- Legitimate use of the productConfirm the use of formulations approved by the Ministry of Health, Labour and Welfare.
- Thorough counselingAbility to properly explain risks and benefits.
- After-care systemIt is ideal to have a system in place to address any issues that may arise after the procedure.
Answers to common concerns about Botox
Won't my facial expressions disappear?
With appropriate dosing, you can expect wrinkle improvement while maintaining natural facial expressions.
Isn't long-term use dangerous?
It has been approved for medical use since 1989 and for cosmetic purposes (frown lines) since 2002, with a long clinical track record. Regarding long-term safety, for example, multiple long-term observational studies on cosmetic use have been reported. In one such review, patients who received regular repeated injections over a maximum 5-year period for frown line treatment were followed up, and the study concluded that no new, unexpected serious adverse events or findings suggestive of systemic cumulative toxicity were observed[6]. However, it is important to understand that such observational studies have limitations due to selection bias, such as not including data from patients lost to follow-up. As a point of discussion in long-term use, it has been noted that very rarely, neutralizing antibodies against botulinum toxin may be produced, potentially reducing efficacy, and adherence to appropriate dosage and injection intervals is recommended.
What about use during pregnancy and breastfeeding?
Botox use during pregnancy and breastfeeding is generally recommended to be avoided. We recommend consulting with a specialist physician.
Can antibody formation eliminate the effect?
While antibody formation against botulinum toxin may reduce efficacy, the risk is reported to be extremely low.
If you think, "I wonder what would be right for my case?"
Book a free consultation
There is no high-pressure sales. Please feel free to contact us.
Summary: Understanding Botox safety
The safety profile of Botox based on clinical data can be summarized in the following key points.
- Main risks are minor and transient:According to a large-scale meta-analysis[1], the most common adverse effects are injection site reactions (pain, swelling, etc.) or headache, and the incidence of serious events is low.
- Serious risks are situation-specific:Serious adverse effects listed in the package insert, such as swallowing difficulties, are mainly reported in high-dose treatments or patients with specific risk factors, and are extremely rare with cosmetic use on the upper face.
- Long-term safety is also being confirmed:5-year follow-up study[2]However, no serious cumulative toxicity under appropriate use has been reported from these and other sources, though some unclear points remain, such as the risk of antibody production.
- Physician technique is key to safety:Procedure-related adverse effects such as blepharoptosis[1]can be minimized through the physician's anatomical knowledge, experience, and use of legitimate pharmaceutical products.
Based on these data, maintaining sufficient communication with a trustworthy physician is essential for receiving safe treatment.
Author of this article
Hiromitsu NakamuraPhysician
Zetith Beauty Clinic Ginza, Osaka, Fukuoka
With a track record of presenting research at domestic and international academic conferences, he is also involved in technical guidance and education across Zetith Beauty Clinic. He specializes in precise rhinoplasty based on anatomical principles, pursuing natural results tailored to each individual's skeletal structure and tissues.
References
- Gostimir M, Liou V, Yoon M. Safety of Botulinum Toxin A Injections for Facial Rejuvenation: A Meta-Analysis.Ophthalmic Plastic and Reconstructive Surgery.DOI: 10.1097/IOP.0000000000002169
- Ogilvie P, Rivkin A, Dayan S, et al. OnabotulinumtoxinA for Treatment of Forehead and Glabellar Lines.Dermatologic Surgery.DOI: 10.1097/DSS.0000000000001779
- Tam E, Choo J, Rao P, et al. A Systematic Review on the Effectiveness and Safety of Combining Biostimulators.Aesthetic Plastic Surgery.DOI: 10.1007/s00266-024-04627-5
- Brin MF, Boodhoo A, Pogoda JM, et al. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants.Journal of the American Academy of Dermatology. 2009.
- Dayan SH, Maas CS, Grimes PE, et al. A prospective, multicenter, randomized, double-blind, placebo-controlled study of onabotulinumtoxinA for the treatment of crow's feet lines.Dermatologic Surgery. 2020.
- Carruthers A, Carruthers J, Said S. Long-term safety review of onabotulinumtoxinA for aesthetic use.Journal of Drugs in Dermatology. 2012.